Morgan Stanley Names 3 Biotech Breakthroughs That Offer Investment Opportunities

Morgan Stanley named three biotech breakthroughs that could reward investors, spanning Alzheimer’s drugs, gene editing, and artificial intelligence (AI). Analysts Sean Laaman and Maxwell Skor published the research, and it coincided with the bank’s annual Global Healthcare Conference in New York. Biotech Breakthroughs Carry Multibillion-Dollar Price Tags Morgan Stanley’s report sizes the Alzheimer’s drug market […]